NCT02169791
- Conditions
- Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
- Locations
-
- Northside Hospital Atlanta, Georgia, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,662 public trials
323 recruiting studies
Multiple Myeloma trial results
Completed
Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
NCT02045017
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
- Locations
-
- Krankenhaus der Elisabethinen Linz, I Interne Abteilung Linz, Austria
- Medizinische Universitat Wien Vienna, Austria
- Wilhelminenspital der Stadt Wien Vienna, Austria
- Hopital Dypuytren-CHU de Limoges Limoges, France
NCT02481934
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hospital Universitario 12 de Octubre Madrid, Spain
NCT03383055
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT02849444
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hospital Torrecárdenas Almería, Andalusia, Spain
- Hospital Universitario Puerta del Mar Cadiz, Andalusia, Spain
- Hospital Virgen de la Nieves Granada, Andalusia, Spain
- Hospital Universitario Ciudad de Jaen Jaén, Andalusia, Spain
NCT01720875
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Nottingham University Hospital Nottingham, Nottinghamshire, United Kingdom
- University Hospital Southampton Southampton, United Kingdom
NCT00421525
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Center for Cancer Care Goshen, Indiana, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
NCT01953692
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +27 more
- Locations
-
Not specified
NCT03665155
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Memorial Slaon-Kettering Cancer Center New York, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Southern Cancer Center Mobile, Alabama, United States
- Sansum Clinic - USOR Santa Barbara, California, United States
- Colorado Blood Cancer Institute - PPDS Denver, Colorado, United States
- Rocky Mountain Cancer Centers (Williams) - USOR Denver, Colorado, United States